Evidence map›Paper›PMID 37183797›Full record

ArticleRenal failure2023

Mineral and bone disorder after kidney transplantation: a single-center cohort study.

Li Sun, Zijie Wang, Ming Zheng, Zhou Hang, Jiawen Liu, Xiang Gao, Zeping Gui, Dengyuan Feng, Dongliang Zhang, Qianguang Han and 7 more

Open access · goldAbstract read
In one paragraph

Article in Renal failure, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Li SunDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zijie WangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ming ZhengDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhou HangDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiawen LiuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiang GaoDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zeping GuiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Dengyuan FengDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Dongliang ZhangDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qianguang HanDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Shuang FeiDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Hao ChenDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jun TaoDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhijian HanDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiaobing JuDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Min GuDepartment of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Ruoyun TanDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CNNanjing Medical University · CNSecond Affiliated Hospital of Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe assessment and prevention of mineral and bone disorder (MBD) in kidney transplant recipients (KTRs) have not been standardized. This study aimed to evaluate MBD one year after kidney transplantation (KT) and identify the influencing factors of MBD.

methodsA total of 95 KTRs in our center were enrolled. The changes in bone mineral density (BMD) and bone metabolism biochemical markers, including serum calcium (Ca), phosphorus(P), 25-hydroxyvitamin D(25(OH)vitD), intact parathyroid hormone (iPTH), bone alkaline phosphatase, osteocalcin (OC), type I collagen N-terminal peptide and type I collagen C-terminal peptide (CTx), over one year after KT were assessed. The possible influencing factors of BMD were analyzed. The relationships between bone metabolism biochemical markers were evaluated. The indicators between groups with or without iPTH normalization were also compared.

resultsMBD after KT was manifested as an increased prevalence of hypophosphatemia and bone loss, persistent 25(OH)vitD deficiency, and partially decreased PTH and bone turnover markers (BTMs). Femoral neck BMD was positively correlated with body mass index (BMI) and postoperative 25(OH)vitD, and negatively correlated with postoperative PTH. Lumbar spine BMD was positively correlated with BMI and preoperative TG, and negatively correlated with preoperative OC and CTx. BMD loss was positively associated with glucocorticoid accumulation. Preoperative and postoperative iPTH was negatively correlated with postoperative serum P and 25(OH)vitD, and positively correlated with postoperative Ca and BTMs. The recipients without iPTH normalization, who accounted for 41.0% of all KTRs, presented with higher Ca, lower P, higher BTMs, advanced age, and a higher prevalence of preoperative parathyroid hyperplasia.

conclusionsMBD persisted after KT, showing a close relationship with hyperparathyroidism, high bone turnover, and glucocorticoid accumulation.

Indexed as

Chronic Kidney Disease-Mineral and Bone DisorderHyperparathyroidismKidney TransplantationBiomarkersBone DensityBone RemodelingCohort StudiesCollagen Type IGlucocorticoidsHumansOsteoporosisParathyroid HormonePeptidesBiomarkersCollagen Type IGlucocorticoidsParathyroid HormonePeptideshyperparathyroidismKidney transplantationmineral and bone disorderosteoporosis

Identifiers

PMID37183797
PMCPMC10187110
OpenAlexW4376614093

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.